Ingenovis Health | AI Transformation Index

Ingenovis Health presents the classic healthcare staffing paradox: the end-market demand (human clinicians in hospitals) is structurally permanent and AI-i...

Ingenovis HealthHealthcare (Staffing & Employment Services)Trilantic North America

Overview

Ingenovis Health is a healthcare staffing company that matches nurses, allied health professionals, physicians, and advanced practice clinicians with hospitals and healthcare facilities across the U.S., earning fees for recruitment, credentialing, compliance verification, and placement coordination.

Executive Summary

Ingenovis Health presents the classic healthcare staffing paradox: the end-market demand (human clinicians in hospitals) is structurally permanent and AI-immune, but the company's intermediary coordination role is squarely in the crosshairs of AI-native disintermediation. The AI opportunity is large — a primarily cognitive production function with minimal internal AI capability means massive unrealized compression potential in recruiting, credentialing, and placement workflows that a PE sponsor could unlock. The strategic risk is that the same AI capabilities enabling internal efficiency are simultaneously being deployed by marketplace competitors to bypass traditional staffing agencies entirely, making the timing of AI transformation at Ingenovis both urgent and strategically critical to which side of the disruption curve the company lands on.

Durability

How resilient is this business against AI disruption?

FactorValue

Market Substitutability

7

Profit Pool Migration

4

Barrier to Entry

6

Disintermediation Exposure

3

Switching Costs

4
Total48.0
×

Opportunity

How big a deal is AI for this business?

FactorValue

AI Applicability

8

Improvement Magnitude

8

Transformation Upside

7

Domain Intelligence Amplification

5
Total70.0

58.0

Ciridae AI Score

Durability Rationale

Ingenovis's end market — the physical presence of licensed clinicians in healthcare facilities — is entirely AI-proof, giving the underlying demand structural permanence. However, Ingenovis itself operates as a coordination intermediary between clinicians and facilities, and that intermediary role is precisely where AI-native platforms are applying the most pressure. Disintermediation is the dominant durability threat: direct-connect marketplaces combined with AI-powered credentialing and matching tools could allow hospitals and clinicians to transact without a traditional staffing agency in the middle. Moderate switching costs, multi-vendor hospital procurement practices, and only thin barriers to AI-native entry mean the company's economics are structurally exposed even as clinical demand remains robust.

Opportunity Rationale

The AI opportunity at Ingenovis is substantial and largely unrealized — the entire production function is cognitive and information-processing work that AI can compress dramatically. Credentialing and compliance verification across fifty state jurisdictions is a particularly high-magnitude compression target, and recruiter throughput multiplication is a clear transformation lever: the same expert relationship base could support multiples of current placement volume with AI handling sourcing, screening, and coordination. The domain intelligence layer is real but not exceptional — much of what experienced recruiters know about compliance is codifiable, which makes the opportunity slightly less about amplifying proprietary judgment and more about raw labor compression across a large cognitive workforce.

Key Risks

Durability upside risk: if Ingenovis successfully transforms into an AI-powered talent marketplace with proprietary credentialing infrastructure and deep facility integrations, switching costs and disintermediation risk both improve materially — the current assessment may underweight a platform pivot that several at-scale staffing companies are attempting.

Opportunity downside risk: much of the compression opportunity (credentialing, matching, sourcing) is visible to every staffing competitor and AI-native entrant simultaneously, meaning Ingenovis may not capture the efficiency gains as margin — instead, competitive dynamics could force the savings into lower prices for hospitals or higher pay for clinicians, compressing the agency spread without improving Ingenovis's relative position.

Company Overview

HeadquartersBlue Ash, Ohio, United States
Products / Services
Healthcare staffing solutions for hospitals and patients, Workforce solutions including staffing for nursing, allied health, ancillary services, Specialized programs such as the Ingenovis Health ACT Program (Advocacy, Career, Tools) supporting clinicians, Mobile app platform integrating multiple brands (Trustaff, Fastaff, USN) for job search and profile management, Brands under Ingenovis Health include Trustaff, Fastaff, HealthCare Support, USN, VISTA Staffing, Springboard Health, VitalSolution, and Corazon, each focusing on different healthcare staffing niches and services.
Deal Partners

PE / Ownership History

EventDetails
Ingenovis Health Acquisition of VISTA Staffing Solutions
April 27, 2022
Ingenovis Health acquired VISTA Staffing Solutions from Envision Physician Services. VISTA is a leading locum tenens healthcare staffing company with a network of physicians and advanced practitioners nationwide. This acquisition further diversified Ingenovis Health's service offerings and expanded its ability to address physician and advanced practitioner staffing challenges. VISTA was founded in 1990 and headquartered in Cottonwood Heights, Utah. Davis Polk & Wardwell LLP advised Ingenovis Health, Cornell Capital, and Trilantic North America. William Blair advised Envision Physician Services.
Ingenovis Health Acquisition of HealthCare Support
November 29, 2021
Ingenovis Health, backed by Cornell Capital and Trilantic North America, agreed to acquire HealthCare Support (HSS), a national healthcare staffing platform providing customized hiring solutions across the U.S. HealthCare Support is one of the largest allied healthcare staffing companies, founded in 2003 and headquartered in Orlando, Florida. The acquisition was part of Ingenovis Health's strategy to grow both organically and through acquisitions to expand service offerings and meet increasing demand. Financial terms were not disclosed. Davis Polk advised Cornell Capital, Trilantic North America, and Ingenovis Health. Citizens Bank and UBS Securities acted as joint lead arrangers.
Acquisition of Ingenovis Health by Cornell Capital and Trilantic North America
February 8, 2021
Private equity firms Cornell Capital and Trilantic North America jointly acquired Ingenovis Health, a tech-enabled platform for healthcare staffing based in Cincinnati, Ohio. This transaction marked Cornell Capital's first and Trilantic North America's second transaction in the staffing sector. The deal was a consolidation type and represented Trilantic's 42nd transaction in the United States. The acquisition positioned Ingenovis Health for accelerated growth in healthcare staffing services.

Executives

NameBackground
Benjamin Mirtes
Chief Executive Officer (CEO)
CEO of Ingenovis Health since November 2024, previously CFO from 2021 to 2024. CFO at Ingenovis Health from 2021, played a key role in the company's growth to over $1.5 billion in annual revenue by 2023. Integral in acquisition strategy and integration of multiple healthcare staffing brands. Previously Chief Financial Officer at CVP for nearly 3 years. Director of Corporate Finance at Medpace for 4 years. Manager of Corporate Growth Strategy at Deloitte Consulting for 5 years. Bachelor of Science in Business, cum laude, major in Finance and minor in Political Analysis from Miami University. Named CFO of the Year in 2023 by the Cincinnati Business Courier. Based in Cincinnati, Ohio. Known for strategic expertise leveraging data and technology to drive growth.
Michael Flaim
Chief Financial Officer (CFO)
CFO of Ingenovis Health since October 2024. CFO at MGA Homecare (provider of home health services to pediatric patients) for 6 months. Held multiple financial leadership roles at DaVita Kidney Care including Vice President of Finance and Head of Enterprise Financial Planning & Analysis. Over a decade of experience in healthcare finance. MBA from The University of Chicago Booth School of Business. Based in Denver Metropolitan Area. Brings extensive experience in healthcare, strategic and operational finance, and capital markets.
Lane Greever
Chief Operating Officer (COO)
COO of Ingenovis Health since June 2025. Former COO of Akkodis' $1.2 billion business in the Americas. Global Head of Recruitment with experience leading teams across North America, Asia-Pacific, Europe, Middle East, Africa, and Latin America. Known for driving organizational transformation, integration of global service delivery, and scaling offshore/near-shore capabilities. Oversees Travel Nurse & Allied and Physician Services brands, Marketing, Data Strategy & Analytics, and Operations.
Michelle Savell Sweet
President of USN
President of USN (a brand under Ingenovis Health) since June 2025. Previously served 8 years at Ingenovis Health in various roles including Senior Vice President of USN. Led Fastaff Recruiting and Account Management teams. Most recently Senior Vice President of Sales at Integrity Locums. Leads all aspects of USN operations including job action readiness, client partnerships, recruiting, and clinician deployment.